Macroview Investment Management LLC Bristol Myers Squibb CO Transaction History

Macroview Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$40.25 - $52.99 $40 - $52	1 New	1 $0
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $2,605 - $2,912	45 New	45 $2,000
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $84 - $49,946	-650 Reduced 96.3%	25 $2,000
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $1,537 - $1,843	25 Added 3.85%	675 $49,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $1,315 - $1,538	-24 Reduced 3.56%	650 $38,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $1,181 - $1,540	24 Added 3.69%	674 $43,000
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $26,665 - $31,795	591 Added 1001.69%	650 $31,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $2,876 - $3,730	59 New	59 $3,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.